Life Science Company
Ligand Pharmaceuticals has acquired 13 companies, including 8 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
Ligand Pharmaceuticals’ largest acquisition to date was in 2020, when it acquired Pfenex for $438M. It’s largest disclosed sale occurred in 2020, when it sold Vernalis to HitGen for $25M. Ligand Pharmaceuticals has acquired in 6 different US states, and 2 countries. The Company’s most targeted sectors include life science (93%) and medical products (8%).
Join Mergr and gain access to Ligand Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity14
- M&A Buy Activity13
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 4
- M&A Advisors 4
Unlimited Searches
